Continuous Glucose Monitoring (CGM) Devices Market - Product Outlook and Trend Analysis


The Continuous Glucose Monitoring (CGM) Devices Market is expected to be around $1.1 billion by 2025. Rising incidence of diabetes worldwide, technological advancements in CGM devices (such as advent of artificial pancreas), and rising awareness about the availability of CGM devices are the factors responsible for the growth of this market. However, stringent regulations and expensive CGM devices are set to hamper the market growth.

Continuous Glucose Monitoring (CGM) Devices Market - Product Outlook and Trend Analysis
Transmitter and receivers segment accounted for the largest share of the overall market in 2016, whereas the insulin pumps market is projected to be the fastest-growing segment during the forecast period due to precise insulin delivery, decreasing episodes of severe hypoglycemia and high blood glucose control.

Continuous Glucose Monitoring (CGM) Devices Market - End User Outlook and Trend Analysis
Homecare diagnostics segment held the major share of the global market in 2016, due to efficiency and user-friendly nature of the CGM devices. Patients can use these devices without the technical support from hospital staff. Thus, the insulin can be administered by the patient itself.

Continuous Glucose Monitoring (CGM) Devices Market - Regional Outlook and Trend Analysis
North America accounted for the largest share of the overall market in 2014. This is attributed to increase in the number of obese patients, sedentary lifestyle and high adoption of advanced CGM devices. Asia-Pacific is expected to be the fastest growing region during the forecasted period, due to high patient population with rapidly aging population and increasing patient awareness about the availability of CGM devices with growing disposable income of people.

Continuous Glucose Monitoring (CGM) Devices Market - Competitive Analysis
Abbott Laboratories, Nemaura Medical Inc., Insulet Corporation, Tandem Diabetes Care, Inc., Johnson and Johnson, Dexcom, Inc., F. Hoffmann-La Roche AG, Medtronic, Echo Therapeutics, Inc, Senseonics Holdings, Inc., and GlySens Incorporated are the major players operating in the continuous glucose monitoring devices market.






Comments